The Pharma Letter22m
FDA approves Roche’s Susvimo for DME
The US Food and Drug Administration (FDA) has approved Susvimo (ranibizumab injection) 100mg/mL for the treatment of diabetic ...
The Pharma Letter55m
Turnstone Biologics to explore strategic alternatives
San Diego, USA-based Turnstone Biologics yesterday announced that it has completed an assessment of its business and ...